PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine/Gastroenterology Division, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.\', \'Cancer Biophysics Laboratory, Department of Mechanical and Manufacturing Engineering, University of Cyprus, Nicosia, Cyprus.\', \'Department of Pulmonary and Critical Care Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.\', \'Department of Mechanical Engineering, Sharif University of Technology, Tehran, Iran; Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.\', \'Department of Medicine/Renal Division, Brigham and Women\'s Hospital and Harvard Medical School, Boston, Massachusetts.\', \'Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.\', \'Department of Emergency Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.\', \'Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.\', \'Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. Electronic address: munn@steele.mgh.harvard.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2352-3964(21)00603-410.1016/j.ebiom.2021.103809
?:hasPublicationType
?:journal
  • EBioMedicine
is ?:pmid of
?:pmid
?:pmid
  • 35033853
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.895
?:rankingScore_hIndex
  • 26
is ?:relation_isRelatedTo_publication of
?:title
  • Strategies to minimize heterogeneity and optimize clinical trials in Acute Respiratory Distress Syndrome (ARDS): Insights from mathematical modelling.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all